Point Biopharma Global Inc logo

Point Biopharma Global Inc Share Price Today (NASDAQ: PNT)

Point Biopharma Global Inc share price is $0 & ₹0.00 as on 16 Nov 2023 IST

-13.71

(-100%)

Market is closed - opens 7 PM, 16 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 17 Nov 2023

View live Point Biopharma Global Inc share price in Dollar and Rupees. Guide to invest in Point Biopharma Global Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Point Biopharma Global Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Point Biopharma Global Inc (PNT) Key Statistics

in dollars & INR

Previous Close
$13.71
Open
$13.7
Market Capitalization
$1.4B
Today's Volume
$1.6M
Revenue TTM
$243.7M
EBITDA
$110.4M
Earnings Per Share (EPS)
$1.1
PE Ratio
12.12
Dividend Yield
0.0%
Profit Margin
39.62%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
26.33%

How to invest in Point Biopharma Global Inc Stock (PNT) from India?

It is very easy for Indian residents to invest directly in Point Biopharma Global Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Point Biopharma Global Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Point Biopharma Global Inc or PNT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Point Biopharma Global Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Point Biopharma Global Inc shares which would translate to null fractional shares of Point Biopharma Global Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Point Biopharma Global Inc, in just a few clicks!

Global Institutional Holdings in Point Biopharma Global Inc

  • Bvf Inc

    9.99%

  • BlackRock Inc

    6.00%

  • Vanguard Group Inc

    4.21%

  • State Street Corporation

    3.21%

  • Great Point Partners LLC

    2.84%

  • Deep Track Capital, LP

    2.63%

Analyst Recommendation on Point Biopharma Global Inc

Rating
Trend

Hold

    43%Buy

    56%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Point Biopharma Global Inc(by analysts ranked 0 to 5 stars)

About Point Biopharma Global Inc

POINT Biopharma Global Inc., a radiopharmaceutical company, develops and commercializes radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of prostate cancer, which is under preclinical studies; and PNT-2004, a fibroblast activation protein-alpha inhibitor targeting program being developed for use in various tumor types that is under preclinical studies. In addition, it has product candidates being developed on CanSEEK technology sub-licensed from both Bach Biosciences LLC and Avacta Life Sciences Limited. POINT Biopharma Global Inc. was founded in 2019 and is headquartered in Indianapolis, Indiana.
Organization
Point Biopharma Global Inc
Employees
129
CEO
Mr. Allan Charles Silber
Industry
Miscellaneous

Important FAQs about investing in PNT Stock from India :

Can Indians buy Point Biopharma Global Inc shares?

Yes, Indians can invest in the Point Biopharma Global Inc (PNT) from India.

With INDmoney, you can buy Point Biopharma Global Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Point Biopharma Global Inc at zero transaction cost.

How can I buy Point Biopharma Global Inc shares from India?

It is very easy to buy Point Biopharma Global Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Point Biopharma Global Inc (PNT) be purchased?

Yes, you can buy fractional shares of Point Biopharma Global Inc with INDmoney app.

What are the documents required to start investing in Point Biopharma Global Inc stocks?

To start investing in Point Biopharma Global Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Point Biopharma Global Inc?

Today's market capitalisation of Point Biopharma Global Inc PNT is 1.4B

Who is the Chief Executive Officer (CEO) of Point Biopharma Global Inc ?

Mr. Allan Charles Silber is the current Chief Executive Officer (CEO) of Point Biopharma Global Inc.